177 related articles for article (PubMed ID: 23956437)
1. IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Hatano Y; Tomita H; Kuno T; Saito K; Hara A
J Immunol; 2013 Sep; 191(6):3057-64. PubMed ID: 23956437
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.
Gurtner GJ; Newberry RD; Schloemann SR; McDonald KG; Stenson WF
Gastroenterology; 2003 Dec; 125(6):1762-73. PubMed ID: 14724829
[TBL] [Abstract][Full Text] [Related]
4. Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks.
Shon WJ; Lee YK; Shin JH; Choi EY; Shin DM
Sci Rep; 2015 Nov; 5():17305. PubMed ID: 26610689
[TBL] [Abstract][Full Text] [Related]
5. Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model.
Ito H; Hoshi M; Ohtaki H; Taguchi A; Ando K; Ishikawa T; Osawa Y; Hara A; Moriwaki H; Saito K; Seishima M
J Immunol; 2010 Oct; 185(8):4554-60. PubMed ID: 20844202
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
[TBL] [Abstract][Full Text] [Related]
7. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
8. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Tashita C; Hoshi M; Hirata A; Nakamoto K; Ando T; Hattori T; Yamamoto Y; Tezuka H; Tomita H; Hara A; Saito K
World J Gastroenterol; 2020 Mar; 26(9):918-932. PubMed ID: 32206003
[TBL] [Abstract][Full Text] [Related]
10. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
11. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
[TBL] [Abstract][Full Text] [Related]
12. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacteria alleviate experimentally induced colitis by upregulating indoleamine 2, 3-dioxygenase expression.
Zhao L; Suolang Y; Zhou D; Tang Y; Zhang Y
Microbiol Immunol; 2018 Feb; 62(2):71-79. PubMed ID: 29226383
[TBL] [Abstract][Full Text] [Related]
14. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
[TBL] [Abstract][Full Text] [Related]
15. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
[TBL] [Abstract][Full Text] [Related]
16. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
17. Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
Jackman KA; Brait VH; Wang Y; Maghzal GJ; Ball HJ; McKenzie G; De Silva TM; Stocker R; Sobey CG
Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):471-81. PubMed ID: 21359968
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
19. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
[TBL] [Abstract][Full Text] [Related]
20. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
